For patients who require hemodialysis, the mean plasma half-life of acyclovir during hemodialysis is approximately 5 hours. This results in a 60% decrease in plasma concentrations following a 6-hour dialysis period. Therefore, the patient’s dosing schedule should be adjusted so that an additional dose is administered after each dialysis.
No supplemental dose appears to be necessary after adjustment of the dosing interval.
Acyclovir Suspension was shown to be bioequivalent to acyclovir Capsules (n = 20) and 1 acyclovir 800-mg tablet was shown to be bioequivalent to 4 acyclovir 200-mg capsules (n = 24).
Boxes of 10×10 UD 100 NDC 63739-682-10
Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]
Protect from moisture. Keep this and all medication out of the reach of children.
Carlsbad Technology, Inc.
5922 Farnsworth Court Suite 102
Carlsbad, CA 92008
McKesson Packaging Services
a business unit of McKesson Corporation
7101 Weddingotn Rd., Concord, NC 28027
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL
|ACYCLOVIR acyclovir tablet|
|Labeler — McKesson Packaging Services a business unit of McKesson Corporation (140529962)|
|McKesson Packaging Services a business unit of McKesson Corporation||140529962||REPACK (63739-682)|
Revised: 03/2015 McKesson Packaging Services a business unit of McKesson Corporation
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.